Abilify Sales Data

Rank 1 Current sales rank, all
U.S. Pharmaceuticals.

Last updated: February 2014 (updated quarterly).
The following data shows Abilify U.S. retail sales in Q4 2013 compared to previous quarters.

Date Range Sales Rank Sales ($000) Units (000)
Q4 2013 1 2.23% 0.47%
Q3 2013 1 -1.91% -5.87%
Q2 2013 1 4.70% 1.17%
Q1 2013 1 3.24% -5.89%
Q4 2012 1 (1) 5.20% 4.65%
Q3 2012 2 1.89% 0.80%
Q2 2012 2 (1) 2.91% 0.28%
Q1 2012 3 (1) 4.46% -3.15%
Q4 2011 4 2.66% 2.80%
Q3 2011 4 -1.34% -2.54%
Q2 2011 4 2.79% 0.98%
Q1 2011 4

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Hide
(web4)